Definition Section Sample Clauses

Definition Section. Section 1 of the Agreement is hereby amended to add the following definition: “December 2012 Purchase Agreement: The Securities Purchase Agreement by and among PostRock Energy Corporation, White Deer Energy L.P., White Deer Energy TE L.P. and White Deer Energy FI L.P., dated December 17, 2012.”.
AutoNDA by SimpleDocs
Definition Section. Closing Section 3 Closing Date Section 3(a) Closing Outside Date Section 3 Closing Statement Section 7(a)(xi) Companion Contract Section 31 Companion Contract Buyer Section 31 Companion Contract Properties Section 31 Companion Contract Seller Preamble Code Section 2(c)(i) Construction Projects Section 10(a)(xxii)(C) Continuation Notice Section 19(e) Contract Section 6(c)(ii)(D) Control Section 6(e) Deductible Section 22(e)(iii) Deposit Section 2(a)(i) Diligence Materials Section 2(d) Diligence Room Section 2(d) Disclosed Broker Section 20 Effective Date Preamble Environmental Requirements Section 10(a)(xx)(E) ERISA Section 10(a)(xii) Escrow Holder Section 2(a)(i) Excluded Parcel Section 5(a) Excluded Parcel Cap Section 5(a)(i) Existing Leases Section 1(a)(ii) Existing Title Policies Section 2(d)(v) Express Representations Section 21(d) Failed Condition Party Section 12(d) Fee Owner As defined in the Companion Contract Financing Liens Section 1(e) HAP Section 2(d)(xi) HAP Payments Section 2(d)(xi) Hazardous Materials Section 10(a)(xx)(E) HOA Section 2(d)(xv) HOA Fees Section 7(a)(vii) Improvements Section 2(a)(i) Included Contract Section 6(e) Indemnified Parties Section 19(a) Inspection Period Section 2(e) IRS Section 2(a)(i) Leased Properties Section 12(a)(ix) Leases Section 1(a)(ii) Liability Cap Section 22(c)(iii) Lists Section 10(a)(xi)(B)a Litigation Section 10(a)(x) Loan Assumption Conditions As defined in the Companion Contract Losses Section 22(c) Management Agreements Section 10(a)(xvi) Mandatory Cure Exceptions Section 4(f) Material Defect Section 5(a)(ii) Material Defect Notice Section 5(a)(ii) Non-Refundable Deposit Section 2(a)(i) Occupancy Condition Section 5(e) OFAC Section 10(a)(xi)(A) Order Section 10(a)(xi)(A) Parcel Section 1(a) Permits Section 1(a)(iii) Permitted Encumbrances Section 4(a) Prager PM Acquisition Section 12(a)(vi) Prager PM PSA Section 12(a)(vi) Prager PM PSA Buyer Section 12(a)(vi) Personal Property Section 1(c) Pre-Closing Period Section 20(g) Pre-Closing Tax Period Section 7(a)(v) Prohibited Country Section 10(a)(xi)(B)d Property Section 1(a) Purchase Price Section 2(b) Pursuit Costs Section 14(b) Real Property Section 1(a)(i) Release Claims Section 6(e) Released Parties Section 6(e) Releasing Parties Section 6(e) Rent Rolls Section 10(a)(xiv) Reports Section 19(c) Representation Notice Section 10(c) Security Deposits Section 1(a)(ii)
Definition Section. “Direct Claim” 12.3(b) “Direct Claim Notice” 12.3(b) “Directive” 8.10 “Dispute Notice” 3.4(b) “Dutch Compensation Amount” 2.1(d) “Effective Time” 2.4 “Employee Plans” 4.12(a) “Encumbrance” 1.1 “Equity Right” 1.1 “ERISA” 1.1 “EU Merger Regulation” 4.4(b) “Evaluation Material” 7.7(c) “Exchange Act” 1.1 “Exchange Agent” 2.2 “Exchange Fund” 2.9(a) “Exchange Rate” 1.1 “Exchange Ratio” 2.8(a) “Excluded Assets” 6.4 “Excluded Liabilities” 6.6 “Excluded Taxes” 1.1 “Final Allocations” 2.11(b) “Final Modified Working Capital” 3.4(b) “Final Share Allocation” 2.11(a) “Financial Indebtedness” 1.1 “Former Business Employee” 8.1(a)(ii) “French Business IP Assets” 1.1 “French Business IP Seller” 1.1 “French Business IP Transfer Agreement” 1.1 “GAAP” 1.1 “GmbH Trust” 8.4(b)(ii) “Governmental Authority” 1.1 “HSR Act” 1.1 “Indemnified Party” 12.3(a)(i) “Indemnifying Party” 12.3(a)(i) “Insurance Proceeds” 1.1 “Intellectual Property” 1.1 “Joint Products Agreement” 1.1 “Know-How” 1.1 “Knowledge” 1.1 “Law” 1.1 “Lease” 1.1 “Leased Business Real Property” 1.1 “Liabilities” 1.1 “Licensed Mixed-Use IP Sublicenses” 7.16(b) “Losses” 1.1 “Manufacturing and Supply Agreements” 1.1
Definition Section. Tax Representations Section 10(a)(xx)(I) Tax Return Section 7(a)(i) Tenant Charges Section 7(a)(iii) Tenant Inducement Costs Section 7(a)(iii) Tenants Section 1(a)(ii) Tenant Liens Section 1(c) Transaction Section 23(j) Transfer Taxes Section 8(c) Treasury Regulations Section 2(c)(i) Voluntary Liens Section 4(b) Warranties Section 1(a)(iv)
Definition Section. Assumed Loan Section 1(e)(iii) Assumed Loan Documents Section 1(e)(ii) Books and Records Section 2(d)(xvi)
Definition Section. Released Parties Section 6(e) Releasing Parties Section 6(e) Rent Rolls Section 10(a)(xiv) Reports Section 19(c) Representation Notice Section 10(c) Security Deposits Section 1(a)(ii) Sellers Preamble Seller Cure Matter Section 4(c)(iv)(A) Seller Parties Section 19(b)(A) Seller’s Representations Section 10(b) Survival Period Section 22(b) Taking Section 17 Tax Section 10(a)(xx)(D) Taxable Section 10(a)(xx)(D) Tax Authority Section 10(a)(xx)(D) Tax Return Section 10(a)(xx)(D) Tenant Charges Section 7(a)(i) Tenant Inducement Costs Section 7(a)(iii) Tenant Liens Section 1(c) Tenants Section 1(a)(ii) Title Company Section 4(c)(iv)(A) Transfer Taxes Section 8(c) Treasury Regulations Section 2(c)(i) Warranties Section 1(a)(iv) Warranty Claim Period Section 22(e)(iv) Warranty Notice Section 22(e)(ii)
Definition Section. Recovery Section 16.4(c)(i) (Recovery Allocations) Representatives Section 12.1(c)(iii) (Permitted Disclosures) Requesting Party Section 11.6 (Audit Rights) Required Regulatory Activities Budget Section 4.2(b) (Required Regulatory Activities) Research Budget Section 5.2 (Research Program) Research Plan Section 5.2 (Research Program) Research Product Development Milestone Event Section 10.2(b) (Research Products) Research Product Development Milestone Payment Section 10.2(b) (Research Products) Research Program Section 5.2 (Research Program) Research Program Opt-In Section 5.8(a) (Opt-In Grant) Research Program Opt-In Date Section 5.8(c) (Option Exercise) Research Program Opt-In Effective Date Section 6.1(b)(ii) (Research Programs Effectiveness) Research Program Opt-In Exercise Notice Section 5.8(c) (Option Exercise) Research Program Opt-In Term Section 5.8(c) (Option Exercise) Research Program Subcommittee Section 2.2 (Additional Subcommittees and Working Groups) Research Program Technology Transfer Period Section 5.9 (Technology Transfer) Research Program Technology Transfer Plan Section 5.9 (Technology Transfer) Research Target Combination Section 5.1(a) (Research Target Nomination Right) Research Target Combination License Date Section 5.2 (Research Program) Research Target Combination License Fee Section 5.2 (Research Program) Research Target Nomination Right Section 5.1(a) (Research Target Nomination Right) Research Target Selection Period Section 5.1(a) (Research Target Nomination Right) Research Term Section 5.5 (Research Term) Reverted CD123 Products Section 18.9(b) (Additional Effects of Certain Terminations) Safety/AE Matters Section 7.5 (Adverse Event Reporting; Global Safety Database) Secured Information Section 13.2(c)(i) (Information Security) Securities Regulator Section 12.1(c)(ii) (Permitted Disclosures) Security Incident Section 13.2(c)(iv) (Information Security) Skipped Milestone Section 10.2(c) (Skipped Milestone) Standstill Period Section 19.2(a) (Standstill) Subject Party Section 13.1 (General) Subject Party Audit Section 13.2(a)(iii)(6) (Anti-Corruption Laws) [***] Section 5.1(d) [***] Supplemental Platform Upstream License Section 3.8(a)(i) (Notice of Third Party Platform Rights) Term Section 18.1 (Term) Third Party Allegation Section 16.5(a) (Notice of Allegations) Third Party Platform Rights Section 3.8(a)(i) (Notice of Third Party Platform Rights) Third Party Suit Section 16.5(b) (Notice of Suit)
AutoNDA by SimpleDocs
Definition Section. Manufacturing Contracts” 1.1 “Manufacturing Facilities” 1.1 “Material Supplier” 4.17 “Merger” Recitals “Merger Consideration” 2.8(a) “Merger Sub” Preamble “Mixed Contract” 7.16(a) “Mixed-Use IP License Agreements” 1.1 “Modified Working Capital” 1.1 “Modified Working Capital Calculation” 3.4(a) “Mylan” Preamble “Mylan Certificates” 2.9(b) “Mylan Common Stock” 1.1 “Mylan Disclosure LetterArticle 5Mylan Financial Statements” 1.1 “Mylan Fundamental Representations” 1.1 “Mylan Indemnitees” 12.1 “Mylan Material Adverse Effect” 1.1 “Mylan Options” 5.3(b) “Mylan Parties” Preamble “Mylan Party” Preamble “Mylan Preferred Stock” 1.1 “Mylan SEC Documents” 5.7(a) “Mylan Stock Awards” 5.3(b) “Mylan Stock Plan” 1.1 “Mylan Subsidiaries” 5.2(b) “Mylan Subsidiary” 5.2(b) “New Mylan” Preamble “New Mylan Approval” 5.4(c) “New Mylan Contractual Trust Arrangement” 8.4(b)(ii) “New Mylan Option” 2.10(a) “New Mylan Ordinary Shares” 1.1 “New Mylan Preferred Shares” 1.1 “New Mylan Proposed Amount” 3.4(b) “New Mylan Stock Award” 2.10(b) “New Mylan Transferee DC Plans” 8.5(a) “New Mylan Transferee Pension Plans” 8.4(a) “Order” 1.1 “Original Transaction Agreement” Preamble “Other Xxxxxx Businesses” 1.1 “Other Transferred Intellectual Property” 1.1 “Outside Date” 11.1(b) “Owned Business Real Property” 1.1 “Owned Real Property” 1.1 “Parties” Preamble “Party” Preamble
Definition Section. Losses 12.1 Patent Coordinator 8.3 Party/Parties Preamble Receiving Party 1.27 Recipient Party 7.4 Recovery 9.2. l(d) Sublicense Agreement Payment 6.3.4 Term 10.l Transferring Party 7.4

Related to Definition Section

  • Defined Term Section Action Section 5.11(a) ADS Depositary Section 4.3 Affected Employees Section 5.12(a) Affiliate Section 3.27 Agreement Preamble Antitrust Laws Section 5.4(c) Applicable Laws Section 3.5(a) Assumed Option Section 2.1(c)(iii)(A) Assumed RSU Award Section 2.1(c)(v)(B) Book Entry Share Section 2.1(c)(i) Business Day Section 8.9(k) Cash-Only Shares Section 2.1(c)(i) Certificate of Merger Section 1.1 Class A Ordinary Shares Recitals Class B Ordinary Shares Section 4.3 Closing Section 1.2 Closing Date Section 1.2 Code Section 2.1(c)(iii)(A) Company Preamble Company Acquisition Proposal Section 5.2(a) Company Adverse Recommendation Change Section 5.2(d)(i) Company Benefit Plans Section 3.11(a) Company Certificate Section 2.1(c)(i) Company Common Stock Recitals Company Disclosure Schedule Article 3 Company ESPP Section 5.12(d) Company Material Adverse Effect Section 3.1 Company Material Contract Section 3.23(a) Company Permits Section 3.5(b) Company Permitted Liens Section 3.21(a) Company Preferred Stock Section 3.3 Company Real Property Section 3.5(d) Company Reports Section 3.7(a) Company Representatives Section 5.2(a) Company Restricted Stock Awards Section 2.1(c)(iv) Company Rights Section 2.5 Company Rights Agreement Section 2.5 Company RSU Awards Section 2.1(c)(v) Company Stockholder Approval Section 3.20 Company Stock Option Section 2.1(c)(iii)(A) Company Superior Proposal Section 5.2(d)(ii) Competition Action Section 5.4(c) Confidentiality Agreement Section 5.2(a) control Section 3.27 Cutoff Date Section 8.9(e) Definitive Financing Agreements Section 5.13(b) Delaware Sub Preamble Deposit Agreement Section 4.3 Derivative Transaction Section 3.25(a) DGCL Recitals Dissenting Shares Section 2.1(c)(vii) Dissenting Stockholder Section 2.1(c)(vii) DLLCA Recitals Effective Time Section 1.1 Environmental Laws Section 3.13(a) ERISA Section 3.11(a) ERISA Affiliate Section 3.11(c) Equity Compensation Exchange Ratio Section 2.1(c)(i) Exchange Act Section 3.4 Exchange Agent Section 2.2(a) Exchange Fund Section 2.2(a) Exchange Ratio Section 2.1(c)(i) Excluded Shares Section 2.1(c)(ii) FCPA Section 3.5(e) Fee Section 7.5(b) Final Parent Stock Price Section 2.1(c)(i) Financing Section 5.13(a) Financing Commitments Section 5.13(a) Financing Sources Section 5.13(a) Form F-6 Section 5.7(a) Form S-4 Section 5.7(a) GAAP Section 3.7(b) Governmental Entity Section 3.6(b) Governmental Official Section 3.5(e) Hazardous Materials Section 3.13(b) HSR Act Section 3.6(b) Indemnified Party(ies) Section 5.11(a) IRS Section 3.11(a) Liens Section 3.4 Material Adverse Effect Section 8.9(c) Merger Recitals Merger Consideration Section 2.1(c)(i) Merger Sub Preamble New Financing Commitments Section 5.13(a) Non-U.S. Antitrust Laws Section 5.4(a)(i) Non-U.S. Company Benefit Plan Section 3.11(a) Non-U.S. Parent Benefit Plan Section 4.11(a) NYSE Recitals OFAC Section 3.5(f) Parent Preamble Parent ADS Recitals Parent Adverse Recommendation Change Section 5.16(d)(i) Parent Alternative Proposal Section 5.16(a) Parent Benefit Plans Section 4.11(a) Parent Disclosure Schedule Article 4 Parent Material Adverse Effect Section 4.1 Parent Material Contract Section 4.23(a) Parent Options Section 4.3 Parent Permits Section 4.5(b) Parent Permitted Liens Section 4.21(a) Parent Real Property Section 4.5(d) Parent Representatives Section 5.16(a) Parent Reports Section 4.7(a) Parent Shareholder Approval Section 4.20 Parent Superior Proposal Section 5.16(d)(ii) Parent UK Prospectus Section 5.7(d)(i) Per Share Cash-Only Additional Cash Amount Section 2.1(c)(i) Per Share Cash Amount Section 2.1(c)(i) Per Share Stock Amount Section 2.1(c)(i) Person Section 3.5(e) PFIC Section 4.10(b) Proxy Statement/Prospectus Section 5.7(a) Regulatory Filings Section 3.6(b) Required Jurisdiction Section 6.1(b)(iii) Returns Section 3.10(a) Rule 16b-3 Section 5.9 Xxxxxxxx-Xxxxx Act Section 3.7(a) SEC Section 3.7(a) Securities Act Section 3.6(b) Significant Subsidiary Section 3.4 Subsidiary Section 8.9(d) Surviving Entity Section 1.1 tax(es) Section 3.10(f) Third Party Provision Section 8.3 to the knowledge of Section 8.9(b) UK FSMA Section 2.2(b)(i) UK Prospectus Rules Section 5.7(d)(i) UKLA Section 5.7(d)(i) U.S. Company Benefit Plan Section 3.11(a) U.S. Parent Benefit Plan Section 4.11(a) THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) dated as of February 6, 2011, is by and among Ensco plc, a public limited company organized under the laws of England and Wales (“Parent”), Pride International, Inc., a Delaware corporation (the “Company”), ENSCO Ventures LLC, a Delaware limited liability company and an indirect, wholly owned subsidiary of Parent (“Merger Sub”), and ENSCO International Incorporated, a Delaware corporation and an indirect, wholly-owned subsidiary of Parent (“Delaware Sub”).

  • Term Section End Date 9.1(b)(i) Enforceability Exceptions 3.2(a) Equity Commitment Letter 4.6(a) Equity Financing 4.6(a) Expense Reimbursement 9.3(c) Fairfax . Recitals Financing Commitment Letters 4.6(a) FSC Certification 3.15(a) Guaranteed Obligations 10.11(a) Guarantors 10.11(a) Leased Real Properties 3.14(a) Material Customer 3.23(a)(viii) Material Supplier 3.23(a)(viii) Merger Recitals Merger Amounts 4.6(a) Merger Consideration Recitals Merger Sub Preamble New Benefit Plans 6.3(b) No-Action Letter 1.1 Non-Recourse Party 10.15 Non-U.S. Company Plan 3.20(a) Owned Real Property 3.14(b) Parent Preamble Parent Parties Preamble Parent Related Parties 9.3(f)(i) Parent Termination Fee 9.3(d) Parties Preamble Party Preamble Paying Agent 2.8(a) Payment Fund 2.8(a) Payroll Agents 2.10(f) Premium Cap 6.2(c) Proxy Statement 3.9 Real Property Leases 3.14(a) Registered Intellectual Property 3.17(a) Representatives 7.6(a) Section 409A 2.10(f) SFI Certification 3.15(a) Solvent 4.7 Substitute Debt Financing 7.3(b) Surviving Corporation 2.1 Upfront Per Share Merger Consideration Recitals U.S. Company Plan 3.20(a) Vice President/General Manager Level 5.1(i) Voting and Support Agreement Recitals WARN 3.21(e) Water Rights 3.15(a)

  • Pursuant to Section 3 03 of the Indenture Supplement, on each Distribution Date, the Indenture Trustee shall deposit into the Class A(2016-2) Interest Funding sub-Account the portion of Card Series Finance Charge Amounts allocable to the Class A(2016-2) Notes.

  • SECTION I - DEFINITIONS As used in this Agreement, the following terms shall have the meanings ascribed herein unless otherwise stated or reasonably required by the Agreement, and other forms of any defined words shall have a meaning parallel thereto.

  • Definitions and Scope 1.1 Employees shall have the right to present grievances in accordance with the procedures prescribed in this Article. 1.2 For purposes of this Agreement, a grievance is a dispute concerning the interpretation or application of the terms or provisions of this Agreement. It is intended that this shall not mean administrative matters under the Retirement System and the Group Health Insurance Program.

  • Pursuant to Section 4 01, any amounts collected by a Servicer or the Master Servicer under any insurance policies (other than amounts to be applied to the restoration or repair of the property subject to the related Mortgage or released to the Mortgagor in accordance with the related Servicing Agreement) shall be deposited into the Distribution Account, subject to withdrawal pursuant to Section 4.03. Any cost incurred by the Master Servicer or the related Servicer in maintaining any such insurance (if the Mortgagor defaults in its obligation to do so) shall be added to the amount owing under the Mortgage Loan where the terms of the Mortgage Loan so permit; provided, however, that the addition of any such cost shall not be taken into account for purposes of calculating the distributions to be made to Certificateholders and shall be recoverable by the Master Servicer or such Servicer pursuant to Sections 4.01 and 4.03.

  • Pursuant to Section 2.1 of this Agreement, the Seller conveyed to the Trust all of the Seller’s right, title and interest in its rights and benefits, but none of its obligations or burdens, under the Purchase Agreement including the Seller’s rights under the Purchase Agreement and the delivery requirements, representations and warranties and the cure or repurchase obligations of AmeriCredit thereunder. The Seller hereby represents and warrants to the Trust that such assignment is valid, enforceable and effective to permit the Trust to enforce such obligations of AmeriCredit under the Purchase Agreement. Any purchase by AmeriCredit pursuant to the Purchase Agreement shall be deemed a purchase by the Seller pursuant to this Section 3.2 and the definition of Purchased Receivable.

  • Pursuant to Section 2 1.(b) of the Credit Agreement, the Borrower hereby requests that the Lenders make Revolving Loans to the Borrower in an aggregate principal amount equal to $ .

  • Definitions and Schedules 1.1 Words and phrases contained in this Agreement (whether capitalized or not) that are not defined in this Agreement have the meanings given to them in the Electricity Act, 1998, the Ontario Energy Board Act, 1998, any regulations made under either of those Acts, or the Code. 1.2 The following schedules form part of this Agreement: Schedule A – Application and Connection Cost Agreement (recitals) Schedule B – Single Line Diagram, Connection Point and Location of Facilities (section 2.3) Schedule C – List of Other Contracts (section 3.4) Schedule D – Technical and Operating Requirements (section 4.1(d)) Schedule E – Billing and Settlement Procedures (section 5.3) Schedule F – Contacts for Notice (section 12.1) Schedule G – Dispute Resolution (section 16.1) 1) Where a schedule is to be completed by the Parties, the Parties may not include in that schedule a provision that would be contrary to or inconsistent with the Code or the remainder of this Agreement.

  • UCC Definitions Unless otherwise defined herein or the context otherwise requires, terms for which meanings are provided in the UCC are used in this Security Agreement, including its preamble and recitals, with such meanings.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!